nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—Capecitabine—esophageal cancer	0.33	0.505	CbGbCtD
Trimethoprim—ABCB1—esophageal cancer	0.226	1	CbGaD
Trimethoprim—DHFR—Methotrexate—esophageal cancer	0.155	0.237	CbGbCtD
Trimethoprim—TYMS—Methotrexate—esophageal cancer	0.108	0.165	CbGbCtD
Trimethoprim—CYP2C9—Capecitabine—esophageal cancer	0.0261	0.04	CbGbCtD
Trimethoprim—CYP2C9—Cisplatin—esophageal cancer	0.0132	0.0201	CbGbCtD
Trimethoprim—ABCB1—Cisplatin—esophageal cancer	0.0128	0.0196	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—esophageal cancer	0.0083	0.0127	CbGbCtD
Trimethoprim—Haemolysis—Cisplatin—esophageal cancer	0.00199	0.0409	CcSEcCtD
Trimethoprim—Meningitis aseptic—Methotrexate—esophageal cancer	0.00147	0.0303	CcSEcCtD
Trimethoprim—Anaemia megaloblastic—Methotrexate—esophageal cancer	0.00147	0.0303	CcSEcCtD
Trimethoprim—Allergic cutaneous angiitis—Methotrexate—esophageal cancer	0.00109	0.0224	CcSEcCtD
Trimethoprim—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.00104	0.0214	CcSEcCtD
Trimethoprim—Lung infiltration—Methotrexate—esophageal cancer	0.000739	0.0152	CcSEcCtD
Trimethoprim—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.000706	0.0145	CcSEcCtD
Trimethoprim—Bone marrow depression—Capecitabine—esophageal cancer	0.000689	0.0142	CcSEcCtD
Trimethoprim—Hyperkalaemia—Cisplatin—esophageal cancer	0.00062	0.0128	CcSEcCtD
Trimethoprim—Wheezing—Cisplatin—esophageal cancer	0.000613	0.0126	CcSEcCtD
Trimethoprim—Body temperature increased—Carboplatin—esophageal cancer	0.000607	0.0125	CcSEcCtD
Trimethoprim—Eruption—Methotrexate—esophageal cancer	0.000563	0.0116	CcSEcCtD
Trimethoprim—Bone marrow depression—Methotrexate—esophageal cancer	0.000513	0.0106	CcSEcCtD
Trimethoprim—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000508	0.0105	CcSEcCtD
Trimethoprim—Hyponatraemia—Cisplatin—esophageal cancer	0.00046	0.00947	CcSEcCtD
Trimethoprim—Pancreatitis—Cisplatin—esophageal cancer	0.000388	0.00799	CcSEcCtD
Trimethoprim—Photosensitivity—Capecitabine—esophageal cancer	0.000385	0.00792	CcSEcCtD
Trimethoprim—Vascular purpura—Capecitabine—esophageal cancer	0.000378	0.00777	CcSEcCtD
Trimethoprim—Pancytopenia—Cisplatin—esophageal cancer	0.000376	0.00774	CcSEcCtD
Trimethoprim—Glossitis—Methotrexate—esophageal cancer	0.000376	0.00774	CcSEcCtD
Trimethoprim—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000374	0.0077	CcSEcCtD
Trimethoprim—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000366	0.00754	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000358	0.00737	CcSEcCtD
Trimethoprim—Renal impairment—Capecitabine—esophageal cancer	0.000355	0.00731	CcSEcCtD
Trimethoprim—Dermatitis bullous—Capecitabine—esophageal cancer	0.000353	0.00728	CcSEcCtD
Trimethoprim—Purpura—Capecitabine—esophageal cancer	0.00035	0.00722	CcSEcCtD
Trimethoprim—Renal failure—Cisplatin—esophageal cancer	0.000347	0.00715	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000346	0.00713	CcSEcCtD
Trimethoprim—Lethargy—Capecitabine—esophageal cancer	0.000345	0.0071	CcSEcCtD
Trimethoprim—Stomatitis—Cisplatin—esophageal cancer	0.000344	0.00709	CcSEcCtD
Trimethoprim—Hyponatraemia—Capecitabine—esophageal cancer	0.000339	0.00698	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000334	0.00688	CcSEcCtD
Trimethoprim—Aplastic anaemia—Methotrexate—esophageal cancer	0.000325	0.0067	CcSEcCtD
Trimethoprim—Ataxia—Capecitabine—esophageal cancer	0.000318	0.00654	CcSEcCtD
Trimethoprim—Urinary tract disorder—Cisplatin—esophageal cancer	0.000313	0.00645	CcSEcCtD
Trimethoprim—Connective tissue disorder—Cisplatin—esophageal cancer	0.000312	0.00641	CcSEcCtD
Trimethoprim—Urethral disorder—Cisplatin—esophageal cancer	0.000311	0.0064	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000304	0.00626	CcSEcCtD
Trimethoprim—Eye disorder—Cisplatin—esophageal cancer	0.000296	0.0061	CcSEcCtD
Trimethoprim—Tinnitus—Cisplatin—esophageal cancer	0.000296	0.00609	CcSEcCtD
Trimethoprim—Photosensitivity—Methotrexate—esophageal cancer	0.000286	0.0059	CcSEcCtD
Trimethoprim—Immune system disorder—Cisplatin—esophageal cancer	0.000286	0.0059	CcSEcCtD
Trimethoprim—Mediastinal disorder—Cisplatin—esophageal cancer	0.000286	0.00588	CcSEcCtD
Trimethoprim—Pancytopenia—Capecitabine—esophageal cancer	0.000277	0.00571	CcSEcCtD
Trimethoprim—Malnutrition—Cisplatin—esophageal cancer	0.000276	0.00568	CcSEcCtD
Trimethoprim—Erythema—Cisplatin—esophageal cancer	0.000276	0.00568	CcSEcCtD
Trimethoprim—Neutropenia—Capecitabine—esophageal cancer	0.000273	0.00562	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000267	0.00549	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000266	0.00549	CcSEcCtD
Trimethoprim—Pneumonia—Capecitabine—esophageal cancer	0.000262	0.00539	CcSEcCtD
Trimethoprim—Infestation NOS—Capecitabine—esophageal cancer	0.00026	0.00536	CcSEcCtD
Trimethoprim—Infestation—Capecitabine—esophageal cancer	0.00026	0.00536	CcSEcCtD
Trimethoprim—Depression—Capecitabine—esophageal cancer	0.00026	0.00534	CcSEcCtD
Trimethoprim—Tremor—Cisplatin—esophageal cancer	0.000259	0.00532	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000258	0.00531	CcSEcCtD
Trimethoprim—Lethargy—Methotrexate—esophageal cancer	0.000257	0.00528	CcSEcCtD
Trimethoprim—Renal failure—Capecitabine—esophageal cancer	0.000256	0.00527	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000255	0.00525	CcSEcCtD
Trimethoprim—Stomatitis—Capecitabine—esophageal cancer	0.000254	0.00522	CcSEcCtD
Trimethoprim—Haematuria—Capecitabine—esophageal cancer	0.000248	0.00511	CcSEcCtD
Trimethoprim—Leukopenia—Cisplatin—esophageal cancer	0.000247	0.00509	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000246	0.00507	CcSEcCtD
Trimethoprim—Epistaxis—Capecitabine—esophageal cancer	0.000246	0.00505	CcSEcCtD
Trimethoprim—Agranulocytosis—Capecitabine—esophageal cancer	0.000243	0.005	CcSEcCtD
Trimethoprim—Convulsion—Cisplatin—esophageal cancer	0.000239	0.00492	CcSEcCtD
Trimethoprim—Ataxia—Methotrexate—esophageal cancer	0.000236	0.00487	CcSEcCtD
Trimethoprim—Myalgia—Cisplatin—esophageal cancer	0.000235	0.00484	CcSEcCtD
Trimethoprim—Anxiety—Cisplatin—esophageal cancer	0.000234	0.00482	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000233	0.0048	CcSEcCtD
Trimethoprim—Urinary tract disorder—Capecitabine—esophageal cancer	0.000231	0.00475	CcSEcCtD
Trimethoprim—Connective tissue disorder—Capecitabine—esophageal cancer	0.00023	0.00473	CcSEcCtD
Trimethoprim—Urethral disorder—Capecitabine—esophageal cancer	0.000229	0.00472	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000226	0.00466	CcSEcCtD
Trimethoprim—Anaphylactic shock—Cisplatin—esophageal cancer	0.000225	0.00464	CcSEcCtD
Trimethoprim—Erythema multiforme—Capecitabine—esophageal cancer	0.000221	0.00455	CcSEcCtD
Trimethoprim—Nervous system disorder—Cisplatin—esophageal cancer	0.000221	0.00455	CcSEcCtD
Trimethoprim—Thrombocytopenia—Cisplatin—esophageal cancer	0.000221	0.00454	CcSEcCtD
Trimethoprim—Skin disorder—Cisplatin—esophageal cancer	0.000219	0.0045	CcSEcCtD
Trimethoprim—Eye disorder—Capecitabine—esophageal cancer	0.000218	0.0045	CcSEcCtD
Trimethoprim—Tinnitus—Capecitabine—esophageal cancer	0.000218	0.00449	CcSEcCtD
Trimethoprim—Eosinophilia—Methotrexate—esophageal cancer	0.000215	0.00443	CcSEcCtD
Trimethoprim—Anorexia—Cisplatin—esophageal cancer	0.000215	0.00442	CcSEcCtD
Trimethoprim—Pancreatitis—Methotrexate—esophageal cancer	0.000213	0.00439	CcSEcCtD
Trimethoprim—Immune system disorder—Capecitabine—esophageal cancer	0.000211	0.00435	CcSEcCtD
Trimethoprim—Mediastinal disorder—Capecitabine—esophageal cancer	0.000211	0.00434	CcSEcCtD
Trimethoprim—Pancytopenia—Methotrexate—esophageal cancer	0.000206	0.00425	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000205	0.00422	CcSEcCtD
Trimethoprim—Mental disorder—Capecitabine—esophageal cancer	0.000205	0.00421	CcSEcCtD
Trimethoprim—Malnutrition—Capecitabine—esophageal cancer	0.000203	0.00419	CcSEcCtD
Trimethoprim—Erythema—Capecitabine—esophageal cancer	0.000203	0.00419	CcSEcCtD
Trimethoprim—Neutropenia—Methotrexate—esophageal cancer	0.000203	0.00418	CcSEcCtD
Trimethoprim—Dyspnoea—Cisplatin—esophageal cancer	0.000201	0.00413	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000198	0.00408	CcSEcCtD
Trimethoprim—Decreased appetite—Cisplatin—esophageal cancer	0.000196	0.00403	CcSEcCtD
Trimethoprim—Pneumonia—Methotrexate—esophageal cancer	0.000195	0.00401	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000194	0.004	CcSEcCtD
Trimethoprim—Infestation NOS—Methotrexate—esophageal cancer	0.000194	0.00399	CcSEcCtD
Trimethoprim—Infestation—Methotrexate—esophageal cancer	0.000194	0.00399	CcSEcCtD
Trimethoprim—Depression—Methotrexate—esophageal cancer	0.000193	0.00398	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000192	0.00396	CcSEcCtD
Trimethoprim—Tremor—Capecitabine—esophageal cancer	0.000191	0.00392	CcSEcCtD
Trimethoprim—Renal failure—Methotrexate—esophageal cancer	0.00019	0.00392	CcSEcCtD
Trimethoprim—Stomatitis—Methotrexate—esophageal cancer	0.000189	0.00389	CcSEcCtD
Trimethoprim—Feeling abnormal—Cisplatin—esophageal cancer	0.000186	0.00382	CcSEcCtD
Trimethoprim—Haematuria—Methotrexate—esophageal cancer	0.000185	0.0038	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000183	0.00377	CcSEcCtD
Trimethoprim—Epistaxis—Methotrexate—esophageal cancer	0.000183	0.00376	CcSEcCtD
Trimethoprim—Vertigo—Capecitabine—esophageal cancer	0.000183	0.00376	CcSEcCtD
Trimethoprim—Syncope—Capecitabine—esophageal cancer	0.000182	0.00376	CcSEcCtD
Trimethoprim—Leukopenia—Capecitabine—esophageal cancer	0.000182	0.00375	CcSEcCtD
Trimethoprim—Agranulocytosis—Methotrexate—esophageal cancer	0.000181	0.00372	CcSEcCtD
Trimethoprim—Loss of consciousness—Capecitabine—esophageal cancer	0.000179	0.00368	CcSEcCtD
Trimethoprim—Body temperature increased—Cisplatin—esophageal cancer	0.000178	0.00367	CcSEcCtD
Trimethoprim—Cough—Capecitabine—esophageal cancer	0.000178	0.00365	CcSEcCtD
Trimethoprim—Myalgia—Capecitabine—esophageal cancer	0.000173	0.00357	CcSEcCtD
Trimethoprim—Arthralgia—Capecitabine—esophageal cancer	0.000173	0.00357	CcSEcCtD
Trimethoprim—Anxiety—Capecitabine—esophageal cancer	0.000173	0.00355	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000172	0.00354	CcSEcCtD
Trimethoprim—Urinary tract disorder—Methotrexate—esophageal cancer	0.000172	0.00354	CcSEcCtD
Trimethoprim—Urethral disorder—Methotrexate—esophageal cancer	0.000171	0.00351	CcSEcCtD
Trimethoprim—Confusional state—Capecitabine—esophageal cancer	0.000167	0.00345	CcSEcCtD
Trimethoprim—Hypersensitivity—Cisplatin—esophageal cancer	0.000166	0.00342	CcSEcCtD
Trimethoprim—Erythema multiforme—Methotrexate—esophageal cancer	0.000164	0.00339	CcSEcCtD
Trimethoprim—Shock—Capecitabine—esophageal cancer	0.000163	0.00336	CcSEcCtD
Trimethoprim—Nervous system disorder—Capecitabine—esophageal cancer	0.000163	0.00335	CcSEcCtD
Trimethoprim—Eye disorder—Methotrexate—esophageal cancer	0.000163	0.00335	CcSEcCtD
Trimethoprim—Thrombocytopenia—Capecitabine—esophageal cancer	0.000163	0.00335	CcSEcCtD
Trimethoprim—Tinnitus—Methotrexate—esophageal cancer	0.000162	0.00334	CcSEcCtD
Trimethoprim—Skin disorder—Capecitabine—esophageal cancer	0.000161	0.00332	CcSEcCtD
Trimethoprim—Anorexia—Capecitabine—esophageal cancer	0.000158	0.00326	CcSEcCtD
Trimethoprim—Immune system disorder—Methotrexate—esophageal cancer	0.000157	0.00323	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methotrexate—esophageal cancer	0.000157	0.00323	CcSEcCtD
Trimethoprim—Diarrhoea—Cisplatin—esophageal cancer	0.000154	0.00317	CcSEcCtD
Trimethoprim—Mental disorder—Methotrexate—esophageal cancer	0.000152	0.00314	CcSEcCtD
Trimethoprim—Erythema—Methotrexate—esophageal cancer	0.000151	0.00312	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—esophageal cancer	0.000151	0.00312	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000151	0.00311	CcSEcCtD
Trimethoprim—Insomnia—Capecitabine—esophageal cancer	0.00015	0.00309	CcSEcCtD
Trimethoprim—Dyspnoea—Capecitabine—esophageal cancer	0.000148	0.00305	CcSEcCtD
Trimethoprim—Dyspepsia—Capecitabine—esophageal cancer	0.000146	0.00301	CcSEcCtD
Trimethoprim—Decreased appetite—Capecitabine—esophageal cancer	0.000144	0.00297	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000143	0.00295	CcSEcCtD
Trimethoprim—Vomiting—Cisplatin—esophageal cancer	0.000143	0.00295	CcSEcCtD
Trimethoprim—Rash—Cisplatin—esophageal cancer	0.000142	0.00292	CcSEcCtD
Trimethoprim—Constipation—Capecitabine—esophageal cancer	0.000142	0.00292	CcSEcCtD
Trimethoprim—Dermatitis—Cisplatin—esophageal cancer	0.000142	0.00292	CcSEcCtD
Trimethoprim—Feeling abnormal—Capecitabine—esophageal cancer	0.000137	0.00282	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—esophageal cancer	0.000136	0.0028	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000136	0.0028	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—esophageal cancer	0.000136	0.00279	CcSEcCtD
Trimethoprim—Nausea—Cisplatin—esophageal cancer	0.000134	0.00275	CcSEcCtD
Trimethoprim—Cough—Methotrexate—esophageal cancer	0.000132	0.00272	CcSEcCtD
Trimethoprim—Urticaria—Capecitabine—esophageal cancer	0.000132	0.00272	CcSEcCtD
Trimethoprim—Abdominal pain—Capecitabine—esophageal cancer	0.000131	0.0027	CcSEcCtD
Trimethoprim—Body temperature increased—Capecitabine—esophageal cancer	0.000131	0.0027	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—esophageal cancer	0.000131	0.0027	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—esophageal cancer	0.000129	0.00265	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—esophageal cancer	0.000129	0.00265	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000128	0.00264	CcSEcCtD
Trimethoprim—Confusional state—Methotrexate—esophageal cancer	0.000125	0.00257	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—esophageal cancer	0.000124	0.00254	CcSEcCtD
Trimethoprim—Hypersensitivity—Capecitabine—esophageal cancer	0.000122	0.00252	CcSEcCtD
Trimethoprim—Nervous system disorder—Methotrexate—esophageal cancer	0.000121	0.0025	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—esophageal cancer	0.000121	0.00249	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—esophageal cancer	0.00012	0.00247	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—esophageal cancer	0.000118	0.00243	CcSEcCtD
Trimethoprim—Pruritus—Capecitabine—esophageal cancer	0.000117	0.00242	CcSEcCtD
Trimethoprim—Diarrhoea—Capecitabine—esophageal cancer	0.000114	0.00234	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000113	0.00232	CcSEcCtD
Trimethoprim—Insomnia—Methotrexate—esophageal cancer	0.000112	0.0023	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—esophageal cancer	0.00011	0.00227	CcSEcCtD
Trimethoprim—Dizziness—Capecitabine—esophageal cancer	0.00011	0.00226	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—esophageal cancer	0.000109	0.00224	CcSEcCtD
Trimethoprim—Decreased appetite—Methotrexate—esophageal cancer	0.000107	0.00221	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000107	0.0022	CcSEcCtD
Trimethoprim—Vomiting—Capecitabine—esophageal cancer	0.000106	0.00217	CcSEcCtD
Trimethoprim—Rash—Capecitabine—esophageal cancer	0.000105	0.00216	CcSEcCtD
Trimethoprim—Dermatitis—Capecitabine—esophageal cancer	0.000105	0.00215	CcSEcCtD
Trimethoprim—Headache—Capecitabine—esophageal cancer	0.000104	0.00214	CcSEcCtD
Trimethoprim—Feeling abnormal—Methotrexate—esophageal cancer	0.000102	0.0021	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000101	0.00208	CcSEcCtD
Trimethoprim—Nausea—Capecitabine—esophageal cancer	9.86e-05	0.00203	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—esophageal cancer	9.82e-05	0.00202	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—esophageal cancer	9.77e-05	0.00201	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—esophageal cancer	9.77e-05	0.00201	CcSEcCtD
Trimethoprim—Hypersensitivity—Methotrexate—esophageal cancer	9.11e-05	0.00187	CcSEcCtD
Trimethoprim—Pruritus—Methotrexate—esophageal cancer	8.74e-05	0.0018	CcSEcCtD
Trimethoprim—Diarrhoea—Methotrexate—esophageal cancer	8.46e-05	0.00174	CcSEcCtD
Trimethoprim—Dizziness—Methotrexate—esophageal cancer	8.17e-05	0.00168	CcSEcCtD
Trimethoprim—Vomiting—Methotrexate—esophageal cancer	7.86e-05	0.00162	CcSEcCtD
Trimethoprim—Rash—Methotrexate—esophageal cancer	7.79e-05	0.0016	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—esophageal cancer	7.79e-05	0.0016	CcSEcCtD
Trimethoprim—Headache—Methotrexate—esophageal cancer	7.74e-05	0.00159	CcSEcCtD
Trimethoprim—Nausea—Methotrexate—esophageal cancer	7.34e-05	0.00151	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.4e-05	0.000614	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTT1—esophageal cancer	4.39e-05	0.000612	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	4.39e-05	0.000612	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RB1—esophageal cancer	4.35e-05	0.000607	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP2A6—esophageal cancer	4.34e-05	0.000605	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	4.3e-05	0.0006	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GNG7—esophageal cancer	4.29e-05	0.000599	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	4.29e-05	0.000599	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	4.25e-05	0.000594	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—esophageal cancer	4.22e-05	0.000589	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	4.21e-05	0.000587	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	4.17e-05	0.000581	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.12e-05	0.000574	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	4.11e-05	0.000574	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	4.11e-05	0.000574	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS1—esophageal cancer	4.11e-05	0.000573	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ENO1—esophageal cancer	4.11e-05	0.000573	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PSME2—esophageal cancer	4.05e-05	0.000565	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PSME1—esophageal cancer	4.05e-05	0.000565	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ALDH2—esophageal cancer	4.02e-05	0.000561	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	3.99e-05	0.000556	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	3.94e-05	0.00055	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2A—esophageal cancer	3.92e-05	0.000547	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—RB1—esophageal cancer	3.89e-05	0.000543	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTT1—esophageal cancer	3.83e-05	0.000534	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	3.83e-05	0.000534	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP2A6—esophageal cancer	3.78e-05	0.000528	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND1—esophageal cancer	3.71e-05	0.000517	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFBR2—esophageal cancer	3.63e-05	0.000506	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.59e-05	0.000501	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS1—esophageal cancer	3.59e-05	0.0005	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ENO1—esophageal cancer	3.59e-05	0.0005	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	3.58e-05	0.0005	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PSME2—esophageal cancer	3.53e-05	0.000493	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PSME1—esophageal cancer	3.53e-05	0.000493	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP1B1—esophageal cancer	3.5e-05	0.000488	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SMAD4—esophageal cancer	3.44e-05	0.000479	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2A—esophageal cancer	3.42e-05	0.000477	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—EP300—esophageal cancer	3.41e-05	0.000476	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	3.39e-05	0.000473	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	3.35e-05	0.000467	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	3.34e-05	0.000466	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND1—esophageal cancer	3.31e-05	0.000462	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP19A1—esophageal cancer	3.29e-05	0.000458	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND1—esophageal cancer	3.23e-05	0.000451	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1A—esophageal cancer	3.2e-05	0.000447	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC52A3—esophageal cancer	3.19e-05	0.000445	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BLVRB—esophageal cancer	3.19e-05	0.000445	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	3.19e-05	0.000445	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	3.14e-05	0.000439	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	3.13e-05	0.000436	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.12e-05	0.000435	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP1B1—esophageal cancer	3.05e-05	0.000425	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—EP300—esophageal cancer	3.05e-05	0.000425	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—HMOX1—esophageal cancer	3e-05	0.000418	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—EP300—esophageal cancer	2.98e-05	0.000415	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—esophageal cancer	2.97e-05	0.000415	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.92e-05	0.000408	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND1—esophageal cancer	2.89e-05	0.000403	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ABCB1—esophageal cancer	2.88e-05	0.000402	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP19A1—esophageal cancer	2.87e-05	0.0004	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.85e-05	0.000398	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.83e-05	0.000395	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HIF1A—esophageal cancer	2.81e-05	0.000392	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.8e-05	0.00039	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1A—esophageal cancer	2.8e-05	0.00039	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.79e-05	0.000389	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.78e-05	0.000388	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BLVRB—esophageal cancer	2.78e-05	0.000388	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA1—esophageal cancer	2.71e-05	0.000379	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC10A2—esophageal cancer	2.71e-05	0.000379	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—EP300—esophageal cancer	2.66e-05	0.000371	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—esophageal cancer	2.66e-05	0.000371	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—HMOX1—esophageal cancer	2.62e-05	0.000365	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC52A3—esophageal cancer	2.6e-05	0.000362	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BLVRB—esophageal cancer	2.6e-05	0.000362	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—esophageal cancer	2.59e-05	0.000362	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOS2—esophageal cancer	2.56e-05	0.000357	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOTCH1—esophageal cancer	2.53e-05	0.000353	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ABCB1—esophageal cancer	2.51e-05	0.00035	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA2—esophageal cancer	2.48e-05	0.000346	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.43e-05	0.000338	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.4e-05	0.000335	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA1—esophageal cancer	2.36e-05	0.00033	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.36e-05	0.00033	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.33e-05	0.000325	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.32e-05	0.000324	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—esophageal cancer	2.32e-05	0.000323	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.31e-05	0.000322	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ADH7—esophageal cancer	2.31e-05	0.000322	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CREBBP—esophageal cancer	2.3e-05	0.00032	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.28e-05	0.000318	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.28e-05	0.000318	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.21e-05	0.000308	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA1—esophageal cancer	2.21e-05	0.000308	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—esophageal cancer	2.18e-05	0.000304	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA2—esophageal cancer	2.16e-05	0.000302	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.06e-05	0.000287	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOS3—esophageal cancer	2.06e-05	0.000287	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ADH1B—esophageal cancer	2.02e-05	0.000282	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA2—esophageal cancer	2.02e-05	0.000282	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLCE1—esophageal cancer	2.01e-05	0.00028	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ADH7—esophageal cancer	2.01e-05	0.00028	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.99e-05	0.000278	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.97e-05	0.000275	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TYMP—esophageal cancer	1.93e-05	0.00027	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CREBBP—esophageal cancer	1.92e-05	0.000268	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB2—esophageal cancer	1.92e-05	0.000268	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—esophageal cancer	1.9e-05	0.000266	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.9e-05	0.000265	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—esophageal cancer	1.88e-05	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.88e-05	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.88e-05	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ADH7—esophageal cancer	1.88e-05	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.86e-05	0.000259	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.83e-05	0.000256	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ADH1B—esophageal cancer	1.76e-05	0.000246	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TPI1—esophageal cancer	1.75e-05	0.000244	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.75e-05	0.000244	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.72e-05	0.00024	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—NOS3—esophageal cancer	1.72e-05	0.00024	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.71e-05	0.000239	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.71e-05	0.000239	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TYMP—esophageal cancer	1.68e-05	0.000235	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CREBBP—esophageal cancer	1.68e-05	0.000234	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.68e-05	0.000234	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.65e-05	0.000231	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.65e-05	0.00023	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1A—esophageal cancer	1.64e-05	0.000229	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.64e-05	0.000229	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.62e-05	0.000226	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.61e-05	0.000225	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.6e-05	0.000223	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALOX15—esophageal cancer	1.6e-05	0.000223	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—esophageal cancer	1.58e-05	0.00022	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TYMP—esophageal cancer	1.57e-05	0.00022	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EP300—esophageal cancer	1.56e-05	0.000218	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.53e-05	0.000214	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TPI1—esophageal cancer	1.52e-05	0.000212	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTO1—esophageal cancer	1.52e-05	0.000212	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GNG7—esophageal cancer	1.52e-05	0.000212	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—NOS3—esophageal cancer	1.5e-05	0.00021	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.49e-05	0.000208	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALDOB—esophageal cancer	1.46e-05	0.000204	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.46e-05	0.000203	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA1—esophageal cancer	1.46e-05	0.000203	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.43e-05	0.000199	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TPI1—esophageal cancer	1.42e-05	0.000199	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.42e-05	0.000199	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GAPDH—esophageal cancer	1.41e-05	0.000196	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.4e-05	0.000196	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CRABP1—esophageal cancer	1.39e-05	0.000194	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—esophageal cancer	1.37e-05	0.000192	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.36e-05	0.00019	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—esophageal cancer	1.36e-05	0.00019	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.36e-05	0.000189	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.36e-05	0.000189	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.34e-05	0.000187	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.33e-05	0.000186	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—esophageal cancer	1.33e-05	0.000186	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA2—esophageal cancer	1.33e-05	0.000186	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GNG7—esophageal cancer	1.33e-05	0.000185	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.31e-05	0.000183	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—EP300—esophageal cancer	1.31e-05	0.000183	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.3e-05	0.000182	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ENO1—esophageal cancer	1.27e-05	0.000177	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.27e-05	0.000177	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PSME2—esophageal cancer	1.25e-05	0.000175	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PSME1—esophageal cancer	1.25e-05	0.000175	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALDH2—esophageal cancer	1.24e-05	0.000173	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.24e-05	0.000173	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ADH7—esophageal cancer	1.24e-05	0.000173	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GNG7—esophageal cancer	1.24e-05	0.000173	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTT1—esophageal cancer	1.18e-05	0.000165	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.17e-05	0.000163	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.16e-05	0.000162	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—esophageal cancer	1.16e-05	0.000161	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—EP300—esophageal cancer	1.14e-05	0.000159	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ENO1—esophageal cancer	1.11e-05	0.000154	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS1—esophageal cancer	1.11e-05	0.000154	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.11e-05	0.000154	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.1e-05	0.000154	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PSME2—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PSME1—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.09e-05	0.000152	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.09e-05	0.000151	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.08e-05	0.000151	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TYMP—esophageal cancer	1.04e-05	0.000145	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.03e-05	0.000144	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ENO1—esophageal cancer	1.03e-05	0.000144	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PSME2—esophageal cancer	1.02e-05	0.000142	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PSME1—esophageal cancer	1.02e-05	0.000142	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.02e-05	0.000142	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.01e-05	0.000141	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.84e-06	0.000137	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—esophageal cancer	9.69e-06	0.000135	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.41e-06	0.000131	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TPI1—esophageal cancer	9.38e-06	0.000131	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.38e-06	0.000131	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—HMOX1—esophageal cancer	9.27e-06	0.000129	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.09e-06	0.000127	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALDOB—esophageal cancer	9e-06	0.000126	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.9e-06	0.000124	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.9e-06	0.000124	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.85e-06	0.000123	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1B1—esophageal cancer	8.79e-06	0.000123	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.66e-06	0.000121	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.58e-06	0.00012	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—esophageal cancer	8.46e-06	0.000118	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.27e-06	0.000115	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GNG7—esophageal cancer	8.16e-06	0.000114	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HMOX1—esophageal cancer	8.07e-06	0.000113	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.65e-06	0.000107	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.54e-06	0.000105	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.4e-06	0.000103	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.28e-06	0.000102	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.24e-06	0.000101	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.19e-06	0.0001	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.82e-06	9.51e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ENO1—esophageal cancer	6.82e-06	9.51e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.73e-06	9.38e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PSME2—esophageal cancer	6.72e-06	9.37e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PSME1—esophageal cancer	6.72e-06	9.37e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.94e-06	8.29e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.8e-06	8.09e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.47e-06	7.64e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.45e-06	7.6e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NOS3—esophageal cancer	5.32e-06	7.43e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CREBBP—esophageal cancer	5.18e-06	7.23e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.97e-06	6.94e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.87e-06	6.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.84e-06	6.75e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.77e-06	6.66e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NOS3—esophageal cancer	4.64e-06	6.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NOS3—esophageal cancer	4.33e-06	6.04e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—esophageal cancer	4.24e-06	5.92e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—EP300—esophageal cancer	4.05e-06	5.65e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.96e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—EP300—esophageal cancer	3.53e-06	4.92e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—EP300—esophageal cancer	3.3e-06	4.6e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.19e-06	4.45e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3e-06	4.18e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NOS3—esophageal cancer	2.86e-06	3.99e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.61e-06	3.65e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.61e-06	3.64e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.44e-06	3.4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—EP300—esophageal cancer	2.17e-06	3.03e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.61e-06	2.24e-05	CbGpPWpGaD
